- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Potentially Undervalued Companies
Australian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
38
0 new
Companies with a Value score of at least 3, ordered by Value score
38 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MVP | AU$0.48 | -2.0% | -58.4% | AU$41.9m | AU$3.66 | PS1.2x | E83.4% | 0% | ||
TRJ | AU$1.02 | 2.5% | -44.1% | AU$158.3m | AU$1.13 | PB1.3x | E77.4% | n/a | ||
LGP | AU$0.099 | -1.0% | -46.5% | AU$29.9m | n/a | PS1.2x | E110.1% | n/a | ||
MVP | AU$0.48 | -1.0% | -57.8% | AU$41.9m | AU$3.66 | PS1.2x | E83.4% | 0% | ||
NEU | AU$20.10 | -2.8% | 55.1% | AU$2.6b | AU$28.68 | PE16.4x | E3.4% | n/a | ||
AVH | US$3.12 | 5.8% | -43.0% | US$265.1m | US$7.10 | PS5.2x | E61.3% | n/a | ||
LGP | AU$0.099 | -1.0% | -46.5% | AU$29.9m | n/a | PS1.2x | E110.1% | n/a | ||
AVH | US$3.14 | 6.8% | -42.7% | US$265.1m | US$7.15 | PS5.2x | E61.3% | n/a | ||
BDX | AU$0.12 | -14.8% | n/a | AU$41.1m | n/a | PS11.1x | E60.0% | n/a | ||
NEU | AU$20.17 | -2.5% | 55.3% | AU$2.6b | AU$28.78 | PE16.4x | E3.4% | n/a | ||
BDX | AU$0.12 | -20.7% | 64.3% | AU$41.1m | n/a | PS11.1x | E60.0% | n/a | ||
TRJ | AU$1.04 | 5.9% | -43.9% | AU$158.3m | AU$1.15 | PB1.3x | E77.4% | n/a | ||
MSB | AU$1.15 | -0.4% | -4.6% | AU$1.3b | AU$1.25 | PS115.2x | E48.9% | n/a | ||
IMM | AU$0.34 | 11.7% | 8.1% | AU$477.2m | n/a | PS121.4x | E40.1% | n/a | ||
RAD | AU$0.036 | -2.7% | -64.0% | AU$37.0m | n/a | PS6.2x | E28.7% | n/a | ||
MYXDA | AU$3.47 | -9.4% | n/a | AU$305.4m | AU$5.17 | PB0.5x | E73.5% | 0% | ||
TLX | AU$19.28 | 1.7% | 71.4% | AU$6.5b | AU$23.99 | PE204.1x | E37.1% | n/a | ||
IMM | AU$0.34 | 15.3% | 9.7% | AU$484.3m | n/a | PS123.2x | E40.1% | n/a | ||
RAD | AU$0.035 | -5.4% | -64.6% | AU$37.0m | n/a | PS6.2x | E28.7% | n/a | ||
ACR | AU$0.066 | -1.5% | 29.4% | AU$19.2m | n/a | PS1.7x | E115.3% | 0% | ||
ARX | AU$0.63 | 5.9% | -30.8% | AU$216.9m | n/a | PS3.5x | E99.2% | n/a | ||
ARX | AU$0.63 | 5.0% | -31.7% | AU$216.9m | n/a | PS3.5x | E99.2% | n/a | ||
ACR | AU$0.069 | 1.5% | 38.0% | AU$20.1m | n/a | PS1.8x | E115.3% | 0% | ||
VIT | AU$0.097 | 6.6% | -80.6% | AU$53.6m | n/a | PE5.7x | n/a | 10.8% |